CoChat

Suppression of food intake by Glp1r/Lepr-coexpressing neurons prevents obesity in mouse models

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

The adipose-derived hormone leptin acts via its receptor (LepRb) in the brain to control energy balance. A potentially unidentified population of GABAergic hypothalamic LepRb neurons plays key roles in the restraint of food intake and body weight by leptin. To identify markers for candidate populations of LepRb neurons in an unbiased manner, we performed single-nucleus RNA-Seq of enriched mouse hypothalamic LepRb cells, identifying several previously unrecognized populations of hypothalamic LepRb neurons. Many of these populations displayed strong conservation across species, including GABAergic Glp1r-expressing LepRb (LepRbGlp1r) neurons, which expressed more Lepr than other LepRb cell populations. Ablating Lepr from LepRbGlp1r cells provoked hyperphagic obesity without impairing energy expenditure. Similarly, improvements in energy balance caused by Lepr reactivation in GABA neurons of otherwise Lepr-null mice required Lepr expression in GABAergic Glp1r-expressing neurons. Furthermore, restoration of Glp1r expression in LepRbGlp1r neurons in otherwise Glp1r-null mice enabled food intake suppression by the GLP1R agonist, liraglutide. Thus, the conserved GABAergic LepRbGlp1r neuron population plays crucial roles in the suppression of food intake by leptin and GLP1R agonists.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci157515

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 snRNA-Seq of FACS-enriched hypothalamic LepRb neurons defines known and novel LepRb neuron populations. (A) Genetic diagram for the LepRbSun1-sfGFP mouse line (top), and representative image showing GFP immunoreactivity (black) in the mediobasal hypothalamus of a LepRbSun1-sfGFP mouse (bottom). 3V, third cerebral ventricle. Original magnification, ×10. (B) Experimental diagram for isolation of LepRb nuclei from the hypothalamus for snRNA-Seq. (C) UMAP projection of all 2,879 hypothalamic LepRbSun1-sfGFP neuronal nuclei, colored by cluster. (D) Scaled expression of top marker genes across all cells; colors on left correspond to colors of populations, as in C and E. Lowest expression was set to –2; highest expression was set to 2. (E) Percentage of cells that map to each cluster. (F) Scaled Lepr expression across neuron populations within the LepRb-Sun1 data set. Expression in glia was set to 0 and highest Lepr expression was set to 1.
Figure 1 snRNA-Seq of FACS-enriched hypothalamic LepRb neurons defines known and novel LepRb neuron populations. (A) Genetic diagram for the LepRbSun1-sfGFP mouse line (top), and representative image showing GFP immunoreactivity (black) in the mediobasal hypothalamus of a LepRbSun1-sfGFP mouse (bottom). 3V, third cerebral ventricle. Original magnification, ×10. (B) Experimental diagram for isolation of LepRb nuclei from the hypothalamus for snRNA-Seq. (C) UMAP projection of all 2,879 hypothalamic LepRbSun1-sfGFP neuronal nuclei, colored by cluster. (D) Scaled expression of top marker genes across all cells; colors on left correspond to colors of populations, as in C and E. Lowest expression was set to –2; highest expression was set to 2. (E) Percentage of cells that map to each cluster. (F) Scaled Lepr expression across neuron populations within the LepRb-Sun1 data set. Expression in glia was set to 0 and highest Lepr expression was set to 1.CC BY · PubMed Central
Figure 2 Predominant DMH localization of LepRbGlp1r cells. (A) The number of Glp1r- (left), Npy- (middle), and Pomc-expressing (right) cells across LepRbSun1-sfGFP populations. (B) Representative image showing in situ hybridization for Gfp [LepRb(GFP), green] and Glp1r (magenta) in the hypothalamus of a LepRbEGFP-L10a mouse. Digital zooms of Glp1r (bottom), Gfp (middle), and merged images (top) are shown. Arrowheads indicate cells demonstrating colocalization. Original magnification, ×4. (C) Representative image showing GFP immunoreactivity (-IR) (green) and pSTAT3-IR [LepRb(pSTAT3), magenta] in the hypothalamus of a leptin-treated Glp1rEGFP-L10a mouse. Original magnification, ×4. A digital zoom of the boxed region is shown. (D) Quantification of cells containing GFP+pSTAT3 or GFP alone across hypothalamic nuclei in mice treated similarly as those shown in C (n = 3 male animals were assessed). (E) Representative images of the DMH showing FOS-IR (red) and Glp1r (GFP) in fasted (left; n = 3 male and 1 female animal) or fasted and refed with high-fat diet (right; n = 2 male and 2 female animals) Glp1rEGFP-L10a mice. Original magnification, ×4. Insets show digital zooms of the boxed regions. Quantification of FOS+GFP/GFP neurons is shown in the graph. Scale bar: 200 μm. ***P < 0.001 by Student’s t test.
Figure 2 Predominant DMH localization of LepRbGlp1r cells. (A) The number of Glp1r- (left), Npy- (middle), and Pomc-expressing (right) cells across LepRbSun1-sfGFP populations. (B) Representative image showing in situ hybridization for Gfp [LepRb(GFP), green] and Glp1r (magenta) in the hypothalamus of a LepRbEGFP-L10a mouse. Digital zooms of Glp1r (bottom), Gfp (middle), and merged images (top) are shown. Arrowheads indicate cells demonstrating colocalization. Original magnification, ×4. (C) Representative image showing GFP immunoreactivity (-IR) (green) and pSTAT3-IR [LepRb(pSTAT3), magenta] in the hypothalamus of a leptin-treated Glp1rEGFP-L10a mouse. Original magnification, ×4. A digital zoom of the boxed region is shown. (D) Quantification of cells containing GFP+pSTAT3 or GFP alone across hypothalamic nuclei in mice treated similarly as those shown in C (n = 3 male animals were assessed). (E) Representative images of the DMH showing FOS-IR (red) and Glp1r (GFP) in fasted (left; n = 3 male and 1 female animal) or fasted and refed with high-fat diet (right; n = 2 male and 2 female animals) Glp1rEGFP-L10a mice. Original magnification, ×4. Insets show digital zooms of the boxed regions. Quantification of FOS+GFP/GFP neurons is shown in the graph. Scale bar: 200 μm. ***P < 0.001 by Student’s t test.CC BY · PubMed Central
Figure 3 Requirement for Lepr in LepRbGlp1r neurons for the control of food intake and body weight by leptin in male mice. (A) Experimental design showing the generations of Glp1rCre;Leprfl/fl (KOGlp1r or KOG) and Leprfl/fl control animals. (B) Representative images showing leptin-induced pSTAT-IR (LepRb, magenta) and GFP-IR (Glp1r, green) in Glp1rEGFP-L10a (left) and KOGlp1r (right) mice. Original magnification, ×4. (C–H) Body weight (C; n = 7 Ctrl, n = 11 KOGlp1r), food intake (D; n = 7 Ctrl, n = 11 KOGlp1r), body composition (E; n = 7 Ctrl, n = 11 KOGlp1r), serum leptin (F; n = 5 Ctrl, n = 6 KOGlp1r), serum insulin (G; n = 5 Ctrl, n = 6 KOGlp1r), and blood glucose (H; n = 7 Ctrl, n = 11 KOGlp1r) in control (black/gray) and KOGlp1r (purple) male mice. (I) Glycemic response to an i.p. glucose tolerance test in control (black; n = 7) and KOGlp1r (purple; n = 11) male mice. (J and K) VO2 measured in metabolic cages across the diurnal cycle (J) and averaged over 24 hours (K) for KOGlp1r mice (n = 11) and control (n = 8) male mice. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by Student’s t test.
Figure 3 Requirement for Lepr in LepRbGlp1r neurons for the control of food intake and body weight by leptin in male mice. (A) Experimental design showing the generations of Glp1rCre;Leprfl/fl (KOGlp1r or KOG) and Leprfl/fl control animals. (B) Representative images showing leptin-induced pSTAT-IR (LepRb, magenta) and GFP-IR (Glp1r, green) in Glp1rEGFP-L10a (left) and KOGlp1r (right) mice. Original magnification, ×4. (C–H) Body weight (C; n = 7 Ctrl, n = 11 KOGlp1r), food intake (D; n = 7 Ctrl, n = 11 KOGlp1r), body composition (E; n = 7 Ctrl, n = 11 KOGlp1r), serum leptin (F; n = 5 Ctrl, n = 6 KOGlp1r), serum insulin (G; n = 5 Ctrl, n = 6 KOGlp1r), and blood glucose (H; n = 7 Ctrl, n = 11 KOGlp1r) in control (black/gray) and KOGlp1r (purple) male mice. (I) Glycemic response to an i.p. glucose tolerance test in control (black; n = 7) and KOGlp1r (purple; n = 11) male mice. (J and K) VO2 measured in metabolic cages across the diurnal cycle (J) and averaged over 24 hours (K) for KOGlp1r mice (n = 11) and control (n = 8) male mice. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by Student’s t test.CC BY · PubMed Central
Figure 4 Lepr expression in GABAergic LeprGlp1r cells suffices for most leptin action. (A) Expression of Slc17a6 (vGlut2), Slc32a1 (vGat), and Nos1 for LepRbSun1-sfGFP populations. (B) Representative image of GFP-IR (black) in the hypothalami of Slc32a1Flpo;LepRbCre mice on a Flp- and Cre-dependent reporter (RCFLEGFP-L10a) background. (C) Generation of control, LeprFSF-fl/FSF-fl (KO), and Scl32a1FlpO;LeprLSL-fl/LSL-fl (ReVgat) mice to test the role of Lepr in GABAergic neurons for leptin action. (D) Representative images showing leptin-stimulated pSTAT3-IR in control, ReVgat, and KO mice. (E–K) Body weight (E; n = 11 Ctrl, n = 6 ReVgat, n = 6 KO male and n = 11 Ctrl, n = 9 ReVgat, 6 n = KO female animals), food intake (F; n = 11 Ctrl, n = 6 ReV, n = 6 KO male and n = 11 Ctrl, n = 9 ReV, n = 6 KO female animals), body composition (G; n = 10 Ctrl, n = 5 ReV, n = 6 KO male and n = 8 Ctrl, n = 8 ReV, n = 6 KO female animals), serum leptin (H; n = 5 Ctrl, n = 2 ReV, n = 4 KO male and n = 5 Ctrl, n = 2 ReV, n = 3 KO female animals), serum insulin (I; n = 5 Ctrl, n = 2 ReV, n = 2 KO male and n = 6 Ctrl, n = 3 ReV, n = 2 KO female animals), blood glucose (J; n = 11 Ctrl, n = 6 ReV, n = 6 KO male and n = 11 Ctrl, n = 9 ReV, n = 6 KO female animals), and glycemic response to i.p. glucose tolerance test (K) in control (gray; n = 10 male, 9 female), KO (orange; n = 4 male, n = 5 female animals), and ReVgat (gold; n = 6 male, n = 9 female) mice. In H–J, all mice were ad libitum fed in the AM. Data in E and K show the mean ± SEM; letters a–c signify conditions that are statistically different (P < 0.05) by ANOVA with Tukey’s post hoc test. For F–J, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by ANOVA with Dunnett’s post hoc test.
Figure 4 Lepr expression in GABAergic LeprGlp1r cells suffices for most leptin action. (A) Expression of Slc17a6 (vGlut2), Slc32a1 (vGat), and Nos1 for LepRbSun1-sfGFP populations. (B) Representative image of GFP-IR (black) in the hypothalami of Slc32a1Flpo;LepRbCre mice on a Flp- and Cre-dependent reporter (RCFLEGFP-L10a) background. (C) Generation of control, LeprFSF-fl/FSF-fl (KO), and Scl32a1FlpO;LeprLSL-fl/LSL-fl (ReVgat) mice to test the role of Lepr in GABAergic neurons for leptin action. (D) Representative images showing leptin-stimulated pSTAT3-IR in control, ReVgat, and KO mice. (E–K) Body weight (E; n = 11 Ctrl, n = 6 ReVgat, n = 6 KO male and n = 11 Ctrl, n = 9 ReVgat, 6 n = KO female animals), food intake (F; n = 11 Ctrl, n = 6 ReV, n = 6 KO male and n = 11 Ctrl, n = 9 ReV, n = 6 KO female animals), body composition (G; n = 10 Ctrl, n = 5 ReV, n = 6 KO male and n = 8 Ctrl, n = 8 ReV, n = 6 KO female animals), serum leptin (H; n = 5 Ctrl, n = 2 ReV, n = 4 KO male and n = 5 Ctrl, n = 2 ReV, n = 3 KO female animals), serum insulin (I; n = 5 Ctrl, n = 2 ReV, n = 2 KO male and n = 6 Ctrl, n = 3 ReV, n = 2 KO female animals), blood glucose (J; n = 11 Ctrl, n = 6 ReV, n = 6 KO male and n = 11 Ctrl, n = 9 ReV, n = 6 KO female animals), and glycemic response to i.p. glucose tolerance test (K) in control (gray; n = 10 male, 9 female), KO (orange; n = 4 male, n = 5 female animals), and ReVgat (gold; n = 6 male, n = 9 female) mice. In H–J, all mice were ad libitum fed in the AM. Data in E and K show the mean ± SEM; letters a–c signify conditions that are statistically different (P < 0.05) by ANOVA with Tukey’s post hoc test. For F–J, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by ANOVA with Dunnett’s post hoc test.CC BY · PubMed Central
Figure 5 Requirement for Lepr in GABAergic Glp1r cells for the control of energy balance. (A) Generation of LeprFSF-fl/FSF-fl (KO), Scl32a1FlpO;LeprLSL-fl/LSL-fl (ReVgat), and Scl32a1FlpO;Glp1rCre;LeprLSL-fl/LSL-fl (ReVgatKOGlp1r) mice to test the role of Lepr in GABAergic Glp1r neurons for leptin action. Because of the low number of animals produced by the breeding scheme, data from male and female animals has been combined. (B–H) Body weight (B; n = 2 ReVgat, n = 6 ReVgatKOGlp1r, and n = 13 KO male and n = 5 ReVgat, n = 10 ReVgatKOGlp1r, n = 9 KO female animals), food intake (C; n = 2 ReV, n = 3 ReVKOG, n = 8 KO male and n = 3 ReV, n = 7 ReVKOG, n = 8 KO female animals), body composition (D; n = 1 ReV, n = 2 ReVKOG, n = 8 KO male and n = 3 ReV, n = 6 ReVKOG, n = 4 KO female animals), serum leptin and serum insulin (E and F; n = 2 ReV, n = 2 ReVKOG, n = 4 KO male and n = 3 ReV, n = 7 ReVKOG, n = 3 KO female animals), blood glucose (G; n = 2 ReV, n = 6 ReVKOG, n = 13 KO male and n = 5 ReV, n = 10 ReVKOG, n = 9 KO female animals), and glycemic response to i.p. glucose tolerance test (H) in RevGAT (gold; n = 1 male and n = 5 female), KO (orange; n = 8 male and n = 5 female), and RevGATKOGlp1r (green; n = 2 male and n = 6 female) mice. In F and G, all mice were ad libitum fed in the AM. Data in B and H show the mean ± SEM; different letters signify conditions that are statistically different (P < 0.05) by ANOVA with Tukey’s post hoc test. For C–H, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by ANOVA with Dunnett’s post hoc test.
Figure 5 Requirement for Lepr in GABAergic Glp1r cells for the control of energy balance. (A) Generation of LeprFSF-fl/FSF-fl (KO), Scl32a1FlpO;LeprLSL-fl/LSL-fl (ReVgat), and Scl32a1FlpO;Glp1rCre;LeprLSL-fl/LSL-fl (ReVgatKOGlp1r) mice to test the role of Lepr in GABAergic Glp1r neurons for leptin action. Because of the low number of animals produced by the breeding scheme, data from male and female animals has been combined. (B–H) Body weight (B; n = 2 ReVgat, n = 6 ReVgatKOGlp1r, and n = 13 KO male and n = 5 ReVgat, n = 10 ReVgatKOGlp1r, n = 9 KO female animals), food intake (C; n = 2 ReV, n = 3 ReVKOG, n = 8 KO male and n = 3 ReV, n = 7 ReVKOG, n = 8 KO female animals), body composition (D; n = 1 ReV, n = 2 ReVKOG, n = 8 KO male and n = 3 ReV, n = 6 ReVKOG, n = 4 KO female animals), serum leptin and serum insulin (E and F; n = 2 ReV, n = 2 ReVKOG, n = 4 KO male and n = 3 ReV, n = 7 ReVKOG, n = 3 KO female animals), blood glucose (G; n = 2 ReV, n = 6 ReVKOG, n = 13 KO male and n = 5 ReV, n = 10 ReVKOG, n = 9 KO female animals), and glycemic response to i.p. glucose tolerance test (H) in RevGAT (gold; n = 1 male and n = 5 female), KO (orange; n = 8 male and n = 5 female), and RevGATKOGlp1r (green; n = 2 male and n = 6 female) mice. In F and G, all mice were ad libitum fed in the AM. Data in B and H show the mean ± SEM; different letters signify conditions that are statistically different (P < 0.05) by ANOVA with Tukey’s post hoc test. For C–H, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by ANOVA with Dunnett’s post hoc test.CC BY · PubMed Central
Figure 6 Expression of Glp1r in Lepr neurons mediates food intake suppression by liraglutide in male mice. (A) Generation of Glp1rLSL/LSL (KO) and LeprCre; Glp1rLSL/LSL (ReLepr) mice to test the sufficiency of Glp1r expression in Lepr cells for food intake suppression by liraglutide. (B–D) Mice were treated with vehicle for 1 day and then treated with liraglutide (400 μg/d, i.p.) for 3 days (days 0–2) and monitored for food intake and body weight. Daily food intake (B), cumulative food intake over the 3-day treatment period (C), and change in body weight over the 3-day treatment period (D) are shown. n = 7 KO animals and 8 ReL animals. Data in shown B mean ± SEM; different letters signify conditions that are statistically different (P < 0.05) by ANOVA with Tukey’s post hoc test. For C and D, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by ANOVA with Tukey’s post hoc test.
Figure 6 Expression of Glp1r in Lepr neurons mediates food intake suppression by liraglutide in male mice. (A) Generation of Glp1rLSL/LSL (KO) and LeprCre; Glp1rLSL/LSL (ReLepr) mice to test the sufficiency of Glp1r expression in Lepr cells for food intake suppression by liraglutide. (B–D) Mice were treated with vehicle for 1 day and then treated with liraglutide (400 μg/d, i.p.) for 3 days (days 0–2) and monitored for food intake and body weight. Daily food intake (B), cumulative food intake over the 3-day treatment period (C), and change in body weight over the 3-day treatment period (D) are shown. n = 7 KO animals and 8 ReL animals. Data in shown B mean ± SEM; different letters signify conditions that are statistically different (P < 0.05) by ANOVA with Tukey’s post hoc test. For C and D, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by ANOVA with Tukey’s post hoc test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 56

Metadata

Authors
Rupp, A. C., Tomlinson, A. J., Affinati, A. H., Yacawych, W. T., Duensing, A. M., True, C., Lindsley, S. R., Kirigiti, M. A., MacKenzie, A., Polex-Wolf, J., Li, C., Knudsen, L. B., Seeley, R. J., Olson, D. P., Kievit, P., & Myers, M. G.
Affiliations
  • University of Michigan (US)
  • Oregon National Primate Research Center (US)
  • Novo Nordisk (Denmark) (DK)
Corresponding author
Myers, Martin G.
Venue
Journal of Clinical Investigation
Published
2023-10-02
Volume
133
Issue
19
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W4385835219
Cited by
55
References
46
Citations by year
2026: 15 · 2025: 23 · 2024: 15 · 2023: 2
FWCI
8.19
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056731, NIH P30 DK020572, U24DK097771 KR704666)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
leptin receptor, GLP-1 receptor, hypothalamic neurons, GABAergic neurons, feeding inhibition, obesity, energy balance, single-nucleus RNA sequencing, liraglutide, GLP-1 receptor agonists, hyperphagia, energy expenditure
MeSH terms
Animals, Eating, Hypothalamus, Obesity, Mice, Knockout, Leptin, Mice, Receptors, Leptin, GABAergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suppression of food intake by Glp1r/Lepr-coexpressing neurons prevents obesity in mouse models. https://app.cochat.ai/papers/10.1172/jci157515
The paper
Rupp, A. C., Tomlinson, A. J., Affinati, A. H., Yacawych, W. T., Duensing, A. M., True, C., Lindsley, S. R., Kirigiti, M. A., MacKenzie, A., Polex-Wolf, J., Li, C., Knudsen, L. B., Seeley, R. J., Olson, D. P., Kievit, P., & Myers, M. G. (2023). Suppression of food intake by Glp1r/Lepr-coexpressing neurons prevents obesity in mouse models. Journal of Clinical Investigation. https://doi.org/10.1172/jci157515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.